1 withdrawn. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Withdrawn 1 |
Follow SLE: new trials by email Literature Review of SLE trials Research Report on SLE
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of RD06-04 in Patients With Active Autoimmune Diseases RD06-04 cell infusion - SLE, Sclerosis | Early Phase 1 | Withdrawn | Nanjing Bioheng Biotech Co., Ltd. | 2024-08-31 | 2026-02-03 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Neuromyelitis Optica (1) · Sclerosis (1)
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Cardiovascular Diseases (1) · Cranial Nerve Diseases (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Eye Diseases (1) · Immune System Diseases (1) · Myelitis, Transverse (1) · Nervous System Diseases (1) · Optic Nerve Diseases (1) · Optic Neuritis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Skin Diseases (1)
Nanjing Bioheng Biotech Co., Ltd. (1)
China (1)